These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37936014)
1. Use of Resonant Acoustic Mixing Technology for Ultra-Low-Dose Blending in a Single-Step Mixing Process. Frey KA; Baker H; Purcell DK; Lewis AL; Engers DA Pharm Res; 2024 Jan; 41(1):165-183. PubMed ID: 37936014 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Resonant Acoustic Mixing for Low-Dose Pharmaceutical Powder Blends. Gupta S; Pu YE; Li M; Li Z; Osorio JG AAPS PharmSciTech; 2022 Apr; 23(5):126. PubMed ID: 35474151 [TBL] [Abstract][Full Text] [Related]
3. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug. Alyami H; Dahmash E; Bowen J; Mohammed AR PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454 [TBL] [Abstract][Full Text] [Related]
4. Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging. Bakri B; Weimer M; Hauck G; Reich G Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):78-89. PubMed ID: 26455421 [TBL] [Abstract][Full Text] [Related]
5. Mixing of low-dose cohesive drug and overcoming of pre-blending step using a new gentle-wing high-shear mixer granulator. Alsulays BB; Fayed MH; Alalaiwe A; Alshahrani SM; Alshetaili AS; Alshehri SM; Alanazi FK Drug Dev Ind Pharm; 2018 Sep; 44(9):1520-1527. PubMed ID: 29718720 [TBL] [Abstract][Full Text] [Related]
6. Enhanced blend uniformity and flowability of low drug loaded fine API blends via dry coating: The effect of mixing time and excipient size. Kim SS; Castillo C; Cheikhali M; Darweesh H; Kossor C; Davé RN Int J Pharm; 2023 Mar; 635():122722. PubMed ID: 36796658 [TBL] [Abstract][Full Text] [Related]
7. Continuous Mixing Technology: Characterization of a Vertical Mixer Using Residence Time Distribution. Lee KT; Kimber JA; Cogoni G; Brandon JK; Wilsdon D; Verrier HM; Grieb S; Blackwood DO; Jain AC; Doshi P J Pharm Sci; 2021 Jul; 110(7):2694-2702. PubMed ID: 33607187 [TBL] [Abstract][Full Text] [Related]
8. Impact of Silica Dry Coprocessing with API and Blend Mixing Time on Blend Flowability and Drug Content Uniformity. Kim SS; Seetahal A; Amores N; Kossor C; Davé RN J Pharm Sci; 2023 Aug; 112(8):2124-2136. PubMed ID: 37230252 [TBL] [Abstract][Full Text] [Related]
9. In-line and Real-time Monitoring of Resonant Acoustic Mixing by Near-infrared Spectroscopy Combined with Chemometric Technology for Process Analytical Technology Applications in Pharmaceutical Powder Blending Systems. Tanaka R; Takahashi N; Nakamura Y; Hattori Y; Ashizawa K; Otsuka M Anal Sci; 2017; 33(1):41-46. PubMed ID: 28070073 [TBL] [Abstract][Full Text] [Related]
10. In-line quantification of drug and excipients in cohesive powder blends by near infrared spectroscopy. Liew CV; Karande AD; Heng PW Int J Pharm; 2010 Feb; 386(1-2):138-48. PubMed ID: 19922776 [TBL] [Abstract][Full Text] [Related]
11. Machine Learning-Enabled NIR Spectroscopy in Assessing Powder Blend Uniformity: Clear-Up Disparities and Biases Induced by Physical Artefacts. Muthudoss P; Tewari I; Chi RLR; Young KJ; Ann EYC; Hui DNS; Khai OY; Allada R; Rao M; Shahane S; Das S; Babla I; Mhetre S; Paudel A AAPS PharmSciTech; 2022 Oct; 23(7):277. PubMed ID: 36229571 [TBL] [Abstract][Full Text] [Related]
12. Effects of electrostatic charging on pharmaceutical powder blending homogeneity. Pu Y; Mazumder M; Cooney C J Pharm Sci; 2009 Jul; 98(7):2412-21. PubMed ID: 18855912 [TBL] [Abstract][Full Text] [Related]
13. Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate. Le VN; Hoang Thi TH; Robins E; Flament MP AAPS PharmSciTech; 2012 Jun; 13(2):477-84. PubMed ID: 22399285 [TBL] [Abstract][Full Text] [Related]
14. Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP. Muselík J; Franc A; Doležel P; Goněc R; Krondlová A; Lukášová I Acta Pharm; 2014 Sep; 64(3):355-67. PubMed ID: 25296681 [TBL] [Abstract][Full Text] [Related]
15. Development of a continuous direct compression platform for low-dose drug products. Van Snick B; Holman J; Vanhoorne V; Kumar A; De Beer T; Remon JP; Vervaet C Int J Pharm; 2017 Aug; 529(1-2):329-346. PubMed ID: 28684361 [TBL] [Abstract][Full Text] [Related]
16. Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer. Kornchankul W; Hamed E; Parikh NH; Sakr A Pharmazie; 2002 Jan; 57(1):49-53. PubMed ID: 11836931 [TBL] [Abstract][Full Text] [Related]
17. Streamlining of the Powder Mixing Process based on a Segregation Test. Römerová S; Dammer O; Zámostný P AAPS PharmSciTech; 2021 Jun; 22(5):190. PubMed ID: 34159445 [TBL] [Abstract][Full Text] [Related]
18. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application. Storme-Paris I; Clarot I; Esposito S; Chaumeil JC; Nicolas A; Brion F; Rieutord A; Chaminade P Eur J Pharm Biopharm; 2009 May; 72(1):189-98. PubMed ID: 19059338 [TBL] [Abstract][Full Text] [Related]
20. The Stokes number approach to support scale-up and technology transfer of a mixing process. Willemsz TA; Hooijmaijers R; Rubingh CM; Frijlink HW; Vromans H; van der Voort Maarschalk K AAPS PharmSciTech; 2012 Sep; 13(3):928-33. PubMed ID: 22733375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]